Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Cost-Effectiveness of Dementia Care Mapping in Care-Home Settings: Evaluation of a Randomised Controlled Trial.

Meads DM, Martin A, Griffiths A, Kelley R, Creese B, Robinson L, McDermid J, Walwyn R, Ballard C, Surr CA.

Appl Health Econ Health Policy. 2019 Nov 8. doi: 10.1007/s40258-019-00531-1. [Epub ahead of print]

2.

Cost-Effectiveness of Pain Management Strategies in Advanced Cancer.

Meads DM, O'Dwyer JL, Hulme CT, Lopez RR, Bennett MI.

Int J Technol Assess Health Care. 2019 Jan;35(2):141-149. doi: 10.1017/S0266462319000114. Epub 2019 Mar 15.

3.

Exploration of likely engagement with Monetary Contingency Contracts for weight loss: a questionnaire study.

Sykes-Muskett BJ, Prestwich A, Lawton RJ, Meads DM, Armitage CJ.

Psychol Health Med. 2017 Dec;22(10):1278-1283. doi: 10.1080/13548506.2017.1332373. Epub 2017 May 27.

4.

Cost-Effectiveness of Tight Control of Inflammation in Early Psoriatic Arthritis: Economic Analysis of a Multicenter Randomized Controlled Trial.

O'Dwyer JL, Meads DM, Hulme CT, Mcparland L, Brown S, Coates LC, Moverley AR, Emery P, Conaghan PG, Helliwell PS.

Arthritis Care Res (Hoboken). 2018 Mar;70(3):462-468. doi: 10.1002/acr.23293. Epub 2018 Jan 30.

5.

Cost-effectiveness of outpatient parenteral antibiotic therapy: a simulation modelling approach.

Vargas-Palacios A, Meads DM, Twiddy M, Czoski Murray C, Hulme C, Mitchell ED, Gregson A, Stanley P, Minton J.

J Antimicrob Chemother. 2017 Aug 1;72(8):2392-2400. doi: 10.1093/jac/dkx123.

6.

Patient Preferences for Pain Management in Advanced Cancer: Results from a Discrete Choice Experiment.

Meads DM, O'Dwyer JL, Hulme CT, Chintakayala P, Vinall-Collier K, Bennett MI.

Patient. 2017 Oct;10(5):643-651. doi: 10.1007/s40271-017-0236-x.

7.

Pressure UlceR Programme Of reSEarch (PURPOSE): using mixed methods (systematic reviews, prospective cohort, case study, consensus and psychometrics) to identify patient and organisational risk, develop a risk assessment tool and patient-reported outcome Quality of Life and Health Utility measures.

Nixon J, Nelson EA, Rutherford C, Coleman S, Muir D, Keen J, McCabe C, Dealey C, Briggs M, Brown S, Collinson M, Hulme CT, Meads DM, McGinnis E, Patterson M, Czoski-Murray C, Pinkney L, Smith IL, Stevenson R, Stubbs N, Wilson L, Brown JM.

Southampton (UK): NIHR Journals Library; 2015 Sep.

8.

Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial.

Coates LC, Moverley AR, McParland L, Brown S, Navarro-Coy N, O'Dwyer JL, Meads DM, Emery P, Conaghan PG, Helliwell PS.

Lancet. 2015 Dec 19;386(10012):2489-98. doi: 10.1016/S0140-6736(15)00347-5. Epub 2015 Oct 1.

9.

Patient Acceptability of the Yorkshire Dialysis Decision Aid (YoDDA) Booklet: A Prospective Non-Randomized Comparison Study Across 6 Predialysis Services.

Winterbottom AE, Gavaruzzi T, Mooney A, Wilkie M, Davies SJ, Crane D, Tupling K, Baxter PD, Meads DM, Mathers N, Bekker HL.

Perit Dial Int. 2016 Jul-Aug;36(4):374-81. doi: 10.3747/pdi.2014.00274. Epub 2015 Oct 1.

10.
11.

The cost-effectiveness of primary care referral to a UK commercial weight loss programme.

Meads DM, Hulme CT, Hall P, Hill AJ.

Clin Obes. 2014 Dec;4(6):324-32. doi: 10.1111/cob.12077.

PMID:
25826162
12.

Costs of cancer care for use in economic evaluation: a UK analysis of patient-level routine health system data.

Hall PS, Hamilton P, Hulme CT, Meads DM, Jones H, Newsham A, Marti J, Smith AF, Mason H, Velikova G, Ashley L, Wright P.

Br J Cancer. 2015 Mar 3;112(5):948-56. doi: 10.1038/bjc.2014.644. Epub 2015 Jan 20.

13.

Health State Utilities for Pressure Ulcers - A Comparison of Condition-Specific and Generic Measures and Time-Trade-Off (Tto).

Meads DM, Czoski-Murray C, Rutherford C, Dealey C, McGinnis E, Stubbs N, Wilson L, Nixon J, Hulme CT, McCabe C.

Value Health. 2014 Nov;17(7):A610. doi: 10.1016/j.jval.2014.08.2137. Epub 2014 Oct 26. No abstract available.

14.

A Utility Algorithm forthe Pressure Ulcer Quality of Life - Utility Instrument (Puqol-Ui).

Czoski MC, Meads DM, McCabe C, Edlin R, Rutherford C, Hulme CT, Nixon J.

Value Health. 2014 Nov;17(7):A513. doi: 10.1016/j.jval.2014.08.1582. Epub 2014 Oct 26. No abstract available.

15.

Out With The Old - In With The New: Would New Social Preference Weights For Eq-5d Inevitably Require A Reappraisal of Previous Cost-Effectiveness Determinations?

Kind P, Meads DM.

Value Health. 2014 Nov;17(7):A439. doi: 10.1016/j.jval.2014.08.1144. Epub 2014 Oct 26. No abstract available.

16.

Cost-Utility of Cancer Therapies - the 'Cost' of Different Utility Generation Strategies.

Meads DM, McCabe C, Hulme CT, Edlin R, Kharroubi SA, Browne C, Ford H, Dunn J, Marshall A.

Value Health. 2014 Nov;17(7):A327. doi: 10.1016/j.jval.2014.08.591. Epub 2014 Oct 26. No abstract available.

17.

Lifestyle referral assessment in an acute cardiology setting: study protocol for a randomized controlled feasibility trial.

Hill KM, Walwyn RE, Camidge DC, Meads DM, Murray JY, Reynolds G, Farrin AJ, House AO.

Trials. 2013 Jul 11;14:212. doi: 10.1186/1745-6215-14-212.

18.

The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk.

Fairbairn TA, Meads DM, Hulme C, Mather AN, Plein S, Blackman DJ, Greenwood JP.

Heart. 2013 Jul;99(13):914-20. doi: 10.1136/heartjnl-2013-303722. Epub 2013 May 21.

PMID:
23696198
19.

Serial change in health-related quality of life over 1 year after transcatheter aortic valve implantation: predictors of health outcomes.

Fairbairn TA, Meads DM, Mather AN, Motwani M, Pavitt S, Plein S, Blackman DJ, Greenwood JP.

J Am Coll Cardiol. 2012 May 8;59(19):1672-80. doi: 10.1016/j.jacc.2012.01.035.

20.

Can we rely on the Dermatology Life Quality Index as a measure of the impact of psoriasis or atopic dermatitis?

Twiss J, Meads DM, Preston EP, Crawford SR, McKenna SP.

J Invest Dermatol. 2012 Jan;132(1):76-84. doi: 10.1038/jid.2011.238. Epub 2011 Sep 1.

21.

Testing a workplace physical activity intervention: a cluster randomized controlled trial.

McEachan RR, Lawton RJ, Jackson C, Conner M, Meads DM, West RM.

Int J Behav Nutr Phys Act. 2011 Apr 11;8:29. doi: 10.1186/1479-5868-8-29.

22.

Development and validation of the living with chronic obstructive pulmonary disease questionnaire.

McKenna SP, Meads DM, Doward LC, Twiss J, Pokrzywinski R, Revicki D, Hunter CJ, Glendenning GA.

Qual Life Res. 2011 Sep;20(7):1043-52. doi: 10.1007/s11136-011-9850-6. Epub 2011 Feb 11.

PMID:
21312065
23.

International development of the patient-reported outcome indices for multiple sclerosis (PRIMUS).

McKenna SP, Doward LC, Twiss J, Hagell P, Oprandi NC, Fisk J, Grand'Maison F, Bhan V, Arbizu T, Brassat D, Kohlmann T, Meads DM, Eckert BJ.

Value Health. 2010 Dec;13(8):946-51. doi: 10.1111/j.1524-4733.2010.00767.x.

24.

International development of the Unidimensional Fatigue Impact Scale (U-FIS).

Doward LC, Meads DM, Fisk J, Twiss J, Hagell P, Oprandi NC, Grand'Maison F, Bhan V, Arbizu T, Kohlmann T, Brassat D, Eckert BJ, McKenna SP.

Value Health. 2010 Jun-Jul;13(4):463-8. doi: 10.1111/j.1524-4733.2010.00706.x. Epub 2010 Mar 11.

25.

Effects of method of translation of patient-reported health outcome questionnaires: a randomized study of the translation of the Rheumatoid Arthritis Quality of Life (RAQoL) Instrument for Sweden.

Hagell P, Hedin PJ, Meads DM, Nyberg L, McKenna SP.

Value Health. 2010 Jun-Jul;13(4):424-30. doi: 10.1111/j.1524-4733.2009.00677.x. Epub 2009 Jan 8.

26.

Development and validation of the Asthma Life Impact Scale (ALIS).

Meads DM, McKenna SP, Doward LC, Pokrzywinski R, Revicki D, Hunter C, Glendenning GA.

Respir Med. 2010 May;104(5):633-43. doi: 10.1016/j.rmed.2009.11.023. Epub 2010 Jan 6.

27.

Development and psychometric assessment of the COPD and Asthma Sleep Impact Scale (CASIS).

Pokrzywinski RF, Meads DM, McKenna SP, Glendenning GA, Revicki DA.

Health Qual Life Outcomes. 2009 Dec 7;7:98. doi: 10.1186/1477-7525-7-98.

28.

The development of patient-reported outcome indices for multiple sclerosis (PRIMUS).

Doward LC, McKenna SP, Meads DM, Twiss J, Eckert BJ.

Mult Scler. 2009 Sep;15(9):1092-102. doi: 10.1177/1352458509106513. Epub 2009 Jun 25.

PMID:
19556315
29.

The development and validation of the Unidimensional Fatigue Impact Scale (U-FIS).

Meads DM, Doward LC, McKenna SP, Fisk J, Twiss J, Eckert B.

Mult Scler. 2009 Oct;15(10):1228-38. doi: 10.1177/1352458509106714. Epub 2009 Jun 25.

PMID:
19556314
30.

Further validation and responsiveness assessment of the Herpes Outbreak Impact Questionnaire and Herpes Symptom Checklist.

Meads DM, McKenna SP, Bonney MA, Bloch MT.

Value Health. 2009 Mar-Apr;12(2):397-400. doi: 10.1111/j.1524-4733.2008.00450.x. Epub 2008 Sep 9.

31.

The responsiveness and validity of the CAMPHOR Utility Index.

Meads DM, McKenna SP, Doughty N, Das C, Gin-Sing W, Langley J, Pepke-Zaba J.

Eur Respir J. 2008 Dec;32(6):1513-9. doi: 10.1183/09031936.00069708. Epub 2008 Sep 3.

32.

Development and validation of a preference based measure derived from the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for use in cost utility analyses.

McKenna SP, Ratcliffe J, Meads DM, Brazier JE.

Health Qual Life Outcomes. 2008 Aug 21;6:65. doi: 10.1186/1477-7525-6-65.

33.

The development of the Herpes Symptom Checklist and the Herpes Outbreak Impact Questionnaire.

Doward LC, McKenna SP, Meads DM, Kahler K, Frech F.

Value Health. 2009 Jan-Feb;12(1):139-45. doi: 10.1111/j.1524-4733.2008.00424.x. Epub 2008 Jul 18.

34.

Adaptation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) into French-Canadian and English-Canadian.

Coffin D, Duval K, Martel S, Granton J, Lefebvre MC, Meads DM, Twiss J, McKenna SP.

Can Respir J. 2008 Mar;15(2):77-83. Review. English, French.

35.

Evaluation of the psychometric properties of the Hungarian quality of life in depression scale.

Viola R, Lovas K, Szabo Z, Czenner Z, Meads DM, Soos G, McKenna SP.

Eur Psychiatry. 2008 Jan;23(1):49-52. doi: 10.1016/j.eurpsy.2007.11.003. Epub 2008 Jan 10.

PMID:
18191550
36.

United States validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR).

Gomberg-Maitland M, Thenappan T, Rizvi K, Chandra S, Meads DM, McKenna SP.

J Heart Lung Transplant. 2008 Jan;27(1):124-30. doi: 10.1016/j.healun.2007.10.004.

PMID:
18187098
37.
38.

Cross-cultural inequivalence of dermatology-specific health-related quality of life instruments in psoriasis patients.

Nijsten T, Meads DM, de Korte J, Sampogna F, Gelfand JM, Ongenae K, Evers AW, Augustin M.

J Invest Dermatol. 2007 Oct;127(10):2315-22. Epub 2007 May 10. Erratum in: J Invest Dermatol. 2008 Oct;128(10):2545.

39.

Translation and validation of non-English versions of the Ankylosing Spondylitis Quality of Life (ASQOL) questionnaire.

Doward LC, McKenna SP, Meads DM, Twiss J, Revicki D, Wong RL, Luo MP.

Health Qual Life Outcomes. 2007 Feb 2;5:7.

40.

Adaptation of the RAQoL for use in Australia.

Cox SR, McWilliams L, Massy-Westropp N, Meads DM, McKenna SP, Proudman S.

Rheumatol Int. 2007 May;27(7):661-6. Epub 2006 Dec 29.

PMID:
17195065
41.

Dimensionality of the dermatology life quality index (DLQI): a commentary.

Nijsten T, Meads DM, McKenna SP.

Acta Derm Venereol. 2006;86(3):284-5; author reply 285-6. No abstract available.

42.

The Rheumatoid Arthritis Quality of Life (RAQoL) for Sweden: adaptation and validation.

Hedin PJ, McKenna SP, Meads DM.

Scand J Rheumatol. 2006 Mar-Apr;35(2):117-23.

PMID:
16641045
43.
44.

Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism.

Merza Z, Blumsohn A, Mah PM, Meads DM, McKenna SP, Wylie K, Eastell R, Wu F, Ross RJ.

Int J Androl. 2006 Jun;29(3):381-91. Epub 2005 Dec 22.

PMID:
16390499
45.

The quality of life of parents of children with atopic dermatitis: interpretation of PIQoL-AD scores.

Meads DM, McKenna SP, Kahler K.

Qual Life Res. 2005 Dec;14(10):2235-45.

PMID:
16328903
46.

Adaptation of the rheumatoid arthritis quality of life scale for Estonia.

Tammaru M, McKenna SP, Meads DM, Maimets K, Hansen E.

Rheumatol Int. 2006 May;26(7):655-62. Epub 2005 Sep 24.

PMID:
16184384
47.

Effectiveness of needs-based quality of life instruments.

Doward LC, McKenna SP, Meads DM.

Value Health. 2004 Sep-Oct;7 Suppl 1:S35-8.

48.

Dermatological applications of needs-based quality of life instruments.

Meads DM, McKenna SP, Doward LC.

Value Health. 2004 Sep-Oct;7 Suppl 1:S31-4.

49.

Requirements for quality of life instruments in clinical research.

Doward LC, Meads DM, Thorsen H.

Value Health. 2004 Sep-Oct;7 Suppl 1:S13-6.

Supplemental Content

Loading ...
Support Center